AROS AB – now a member of the Eurofins group

AROS Applied Biotechnology A/S
With today’s press release I am happy to announce that AROS Applied Biotechnolgy A/S  is now a member of the Eurofins group.

Here is a short introduction of our new colleagues from AROS:

  • AROS was founded in the year 2000
  • AROS started as a spin off of from the Aarhus University Hospital and was the first service provider for Affymetrix in Europe
  • AROS is based in Denmark and provides a long term experience in sample preparation, microarray analysis and next generation sequencing (NGS)
  • Nowadays AROS has a leading position in NGS service for pharmaceutical research
  • AROS is an Illumina reference lab for next generation sequencing
  • The main focus in NGS is RNA-Seq and exome sequencing that is accomplished with the exome designs of the leading provider in this area (Illumina TruSeq Exome Enrichment, NimbleGen EZ Capture & Agilent SureSelect)

“AROS is an excellent fit […] with our focus on high-quality next-generation sequencing […]” (Dr. Gilles Martin) and therefore I am confident that this new alliance will help us both in further expanding our experience level in NGS and to benefit from our complementary strength.

I am sure you will hear more about the activities from AROS on our blog and hope you join me in welcoming AROS as a member of Eurofins.

Stephanie Engel

About Stephanie Engel

Stephie's motto: NGS rules. She is thrilled by molecular diagnostics.

No comments yet... Be the first to leave a reply!